Dechra makes success of debut in PP market

By Silas Brown
20 Nov 2019

Dechra Pharmaceuticals, the UK veterinary pharmaceuticals company, has sold euro and dollar US private placement notes, in a debut widely seen as a success.

Santander arranged the transaction, selling €50m of seven year notes and $100m of 10 year PPs according to market sources. This is a new sector for the market, so investors took a while to chew through the credit analysis.

Perhaps the closest company to Dechra to raise PPs ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.